These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 20020666

  • 1. New drug development.
    Cheson BD.
    Clin Adv Hematol Oncol; 2009 Sep; 7(9):556. PubMed ID: 20020666
    [No Abstract] [Full Text] [Related]

  • 2. Development of farnesyltransferase inhibitors for clinical cancer therapy: focus on hematologic malignancies.
    Karp JE, Lancet JE.
    Cancer Invest; 2007 Sep; 25(6):484-94. PubMed ID: 17882662
    [Abstract] [Full Text] [Related]

  • 3. Clinical trials referral resource. Current clinical trials of bortezomib.
    Wright JJ, Zerivitz K, Schoenfeldt M.
    Oncology (Williston Park); 2003 May; 17(5):677-80, 683-6, 691-2. PubMed ID: 12800794
    [No Abstract] [Full Text] [Related]

  • 4. Facilitating patient-centered cancer research and a new era of drug discovery.
    Niederhuber JE.
    Oncologist; 2009 Apr; 14(4):311-2. PubMed ID: 19365096
    [No Abstract] [Full Text] [Related]

  • 5. [Development for and clinical trials of molecular targeting drugs].
    Takashima A, Fukuda H, Shibata T.
    Gan To Kagaku Ryoho; 2010 May; 37(5):822-7. PubMed ID: 20524257
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Hematology: experiences with common national reports on new anti-cancer drugs].
    Kristensen JS, Bukh A.
    Ugeskr Laeger; 2009 Mar 23; 171(13):1089. PubMed ID: 19321084
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Health-related quality of life and symptom assessment in clinical research of patients with hematologic malignancies: where are we now and where do we go from here?
    Efficace F, Novik A, Vignetti M, Mandelli F, Cleeland CS.
    Haematologica; 2007 Dec 23; 92(12):1596-8. PubMed ID: 18055981
    [No Abstract] [Full Text] [Related]

  • 11. Clinical trials referral resource. Current clinical trials for the proteasome inhibitor PS-341.
    Wright J, Hillsamer VL, Gore-Langton RE, Cheson BD.
    Oncology (Williston Park); 2000 Nov 23; 14(11):1589-90, 1593-4, 1597. PubMed ID: 11125942
    [No Abstract] [Full Text] [Related]

  • 12. [Limitations in application of imatinib in hematologic malignancies: are there new principal solutions?].
    Rukavitsyn OA, Pop VP.
    Ter Arkh; 2008 Nov 23; 80(7):80-4. PubMed ID: 18763606
    [No Abstract] [Full Text] [Related]

  • 13. Sixth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin lymphoma.
    Weingart O, Rehan FA, Schulz H, Naumann F, Knauel I, Bohlius CB, Engert A.
    J Natl Cancer Inst; 2007 Sep 05; 99(17):E1. PubMed ID: 17728205
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bortezomib: efficacy comparisons in solid tumors and hematologic malignancies.
    Caravita T, de Fabritiis P, Palumbo A, Amadori S, Boccadoro M.
    Nat Clin Pract Oncol; 2006 Jul 05; 3(7):374-87. PubMed ID: 16826218
    [Abstract] [Full Text] [Related]

  • 17. Bendamustine: a new therapeutic option for hematologic malignancies.
    Cheson BD.
    Clin Adv Hematol Oncol; 2008 Sep 05; 6(9):631-3. PubMed ID: 18827785
    [No Abstract] [Full Text] [Related]

  • 18. New advances in the treatment of hematologic malignancies: focus on topoisomerase I inhibitors. Introduction.
    Kantarjian H.
    Semin Hematol; 1998 Jul 05; 35(3 Suppl 4):1-2. PubMed ID: 9779875
    [No Abstract] [Full Text] [Related]

  • 19. [New agents for solid tumours].
    Raida M.
    Dtsch Med Wochenschr; 2006 Oct 27; 131(43):2407-10. PubMed ID: 17054057
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.